Intermediate type a thalassemia can be treated, through blood transfusion therapy, hematopoietic stem cell transplantation and other methods of treatment.
1. Blood transfusion therapy: it is the main treatment method for thalassemia intermedia type a. The hemoglobin of patients can be maintained above 60~70g/L through blood transfusion therapy. A few patients may have mild bone changes and delayed sexual development, and high blood transfusion therapy can be used for this kind of patients to keep the hemoglobin of patients above 100g/L.
2. Hematopoietic stem cell transplantation: it is the only way to cure this disease clinically. Hematopoietic stem cell transplantation includes bone marrow transplantation, umbilical cord blood transplantation, peripheral blood hematopoietic stem cell transplantation and intrauterine hematopoietic stem cell transplantation. For thalassemia patients with severe clinical manifestations, hematopoietic stem cell transplantation can be considered if the patient’s condition cannot be relieved by blood transfusion alone.
It is recommended that patients with thalassemia intermedia should actively follow the doctor’s instructions.